A

Acticor Biotech SA
PAR:ALACT

Watchlist Manager
Acticor Biotech SA
PAR:ALACT
Watchlist
Price: 0.4 EUR -2.44% Market Closed
Market Cap: 6.3m EUR
Have any thoughts about
Acticor Biotech SA?
Write Note

Acticor Biotech SA
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Acticor Biotech SA
Additional Paid In Capital Peer Comparison

Comparables:
VLA
NANO
G
GNFT
ALERS
OSE

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
A
Acticor Biotech SA
PAR:ALACT
Additional Paid In Capital
€37.4m
CAGR 3-Years
44%
CAGR 5-Years
24%
CAGR 10-Years
11%
Valneva SE
PAR:VLA
Additional Paid In Capital
€593.9m
CAGR 3-Years
22%
CAGR 5-Years
15%
CAGR 10-Years
11%
Nanobiotix SA
PAR:NANO
Additional Paid In Capital
€312.7m
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
22%
G
Genfit SA
PAR:GNFT
Additional Paid In Capital
€446.5m
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
17%
Eurobio Scientific SA
PAR:ALERS
Additional Paid In Capital
€33.6m
CAGR 3-Years
-6%
CAGR 5-Years
-26%
CAGR 10-Years
-12%
OSE Immunotherapeutics SA
PAR:OSE
Additional Paid In Capital
€76.8m
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
N/A

See Also

What is Acticor Biotech SA's Additional Paid In Capital?
Additional Paid In Capital
37.4m EUR

Based on the financial report for Dec 31, 2023, Acticor Biotech SA's Additional Paid In Capital amounts to 37.4m EUR.

What is Acticor Biotech SA's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
11%

Over the last year, the Additional Paid In Capital growth was 60%. The average annual Additional Paid In Capital growth rates for Acticor Biotech SA have been 44% over the past three years , 24% over the past five years , and 11% over the past ten years .

Back to Top